Xigris (Drotrecogin Alfa (Activated)) - Current Clinical Trials

Xigris Related Clinical Trials

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis [Completed]

Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Completed]

A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation [Completed]

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) [Recruiting]

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion [Completed]

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death [Completed]

A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated) [Completed]

An Open Label Study of Severe Sepsis in Adults [Completed]

Hemodynamic and Perfusion Response to Drotrecogin Alfa (Activated) in Patients With Septic Shock [Completed]

Activated Protein C to Treat Acute Lung Injuries [Terminated]

Disease Modification in Toxaemia of Pregnancy [Recruiting]

Activated Protein C and Corticosteroids for Human Septic Shock [Recruiting]

Activated Protein C in Acute Stroke Trial [Recruiting]

Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock [Recruiting]

Predicting Complications in Women With Toxaemia [Recruiting]